Post Reply
1561-1580 of 1767
wow cheer more & immediately it retreated. i wait to collect more!
Lai lai!!
Sgvale ( Date: 22-Dec-2020 14:21) Posted:
|
I dreamt it's going to hit 0.685 later
Agree.. anything lesser than 85c, the Institution funds who bought placement shares and the vested EPF will lose money. And this is very unlikely for these seasoned investors.
I believe the company is worth much more.
EPS is est. 15 to 17c. At 10 times, it should be valued between $1.50 to $1.70.
Dyodd.
Sgvale ( Date: 22-Dec-2020 11:46) Posted:
|
At least 0.80....
Sgvale ( Date: 22-Dec-2020 09:05) Posted:
|
HEALTH AND SCIENCE
I think this is already in the U.S.,Dr. Scott Gottlieb says of new U.K. Covid strain
PUBLISHED MON, DEC 21 20208:27 PM ESTUPDATED MON, DEC 21 20208:31 PM EST
U.K, Covid strain: ' This is already in the U.S.,& rsquo says Dr. Gottlieb (cnbc.com)
U.K, Covid strain: ' This is already in the U.S.,& rsquo says Dr. Gottlieb (cnbc.com)
New COVID-19 Strain in UK: Is It More Dangerous? Do Vaccines Work?
https://www.thequint.com/coronavirus/faq/uk-new-covid-strain-all-you-need-to-know#read-more#read-more
UG main market is at UK and UK is having new virus B.1.1.7.
Looks strong. Next year will be better
Australia detects new UK strain
MON, DEC 21, 2020 - 8:16 PM
[SINGAPORE] Australia said on Monday it had detected cases of the new fast-spreading coronavirus strain identified in the United Kingdom, while Hong Kong and India said they would suspend flights from Britain.
Two travellers from the United Kingdom to Australia' s New South Wales state...
Australia detects new UK strain, Government & Economy - THE BUSINESS TIMES
look@bright ( Date: 21-Dec-2020 20:22) Posted:
|
tomorrow uptrend for all glove counters
I won't sell all my medical stocks. Let nay sayers and other greedy investors pay the price for medical stock price escalation.
Situations will change as virus mutates and changed in characteristics, so basic essential medical supplies will still be needed.
Lately news from London need to be cautious when we open our border slightly wider.
Exercise personal care and observe social distancing etc
Time is not ready for celebration yet. Don't go all out to celebrate 100 %, i saw vivo city areas so crowded yesterday, I am scared.
Lately news from London need to be cautious when we open our border slightly wider.
Exercise personal care and observe social distancing etc
Time is not ready for celebration yet. Don't go all out to celebrate 100 %, i saw vivo city areas so crowded yesterday, I am scared.
Picking up durians..
It seems the sell down has stopped. Not only for UG, there are many medical counters have the same patterns.
Early birds please rise.
Cheap cheap now
If it even reaches $0.70 I will be happy.
Let alone $1.70.
Let alone $1.70.
The vaccines approved for emergency use so far do not change the Covid19 situation overnight. It will take a long time to achieve herd immunity (if ever possible). Everyday cases around the world are hitting record high and PPE and gloves are in still in shortage.
A recollection of the CIMB report after UG results in Nov below.
Backlog orders, forecasted or guided rev and substantial profits will not diminish just due to the vaccine news hype.
Current price 55.5c. TP $1.70c. Upside 206%. DYODD.
--------
UG HEALTHCARE: Higher TP of $1.70
A strong start to the year
Excerpts from CGS-CIMB report (Analyst: Ong Khang Chuen, CFA)
■ 1QFY6/21 net profit of S$22.7m (74-fold increase yoy) was c.45% above our expectations, due to stronger-than-expected ASP increase.
■ Global glove shortage remains acute amid worsening pandemic crisis, and we expect UGHC to be able to raise prices by 10-15% monthly in 2QFY21.
■ Reiterate Add with higher TP of S$1.70. UGHC is trading at an undemanding valuation of 7.5x CY22F P/E (65% discount to Malaysian peers).
1Q FY6/21 results above expectations
UGHC&rsquo s 1QFY21 net profit of S$22.7m (74-fold increase yoy) was above expectations, as we had forecast S$15.7m net profit for the quarter (1Q was 32.2% of our FY21F).
Key surprise was stronger-than-expected ASP hike, which led 1Q topline to rise 170% yoy and GPM to expand by 41.7% pts yoy to 60.6%.
Glove shortage remains acute
We believe global glove shortage remains acute given the worsening pandemic crisis.
UGHC said its distribution companies&rsquo inventory levels remain low, and have to be managed on a very tight schedule based on just-in-time delivery.
We forecast UGHC to record blended ASP growth of +131% yoy in FY21F, boosting its topline to S$364.4m (+153% yoy).
A recollection of the CIMB report after UG results in Nov below.
Backlog orders, forecasted or guided rev and substantial profits will not diminish just due to the vaccine news hype.
Current price 55.5c. TP $1.70c. Upside 206%. DYODD.
--------
UG HEALTHCARE: Higher TP of $1.70
A strong start to the year
Excerpts from CGS-CIMB report (Analyst: Ong Khang Chuen, CFA)
■ 1QFY6/21 net profit of S$22.7m (74-fold increase yoy) was c.45% above our expectations, due to stronger-than-expected ASP increase.
■ Global glove shortage remains acute amid worsening pandemic crisis, and we expect UGHC to be able to raise prices by 10-15% monthly in 2QFY21.
■ Reiterate Add with higher TP of S$1.70. UGHC is trading at an undemanding valuation of 7.5x CY22F P/E (65% discount to Malaysian peers).
1Q FY6/21 results above expectations
UGHC&rsquo s 1QFY21 net profit of S$22.7m (74-fold increase yoy) was above expectations, as we had forecast S$15.7m net profit for the quarter (1Q was 32.2% of our FY21F).
Key surprise was stronger-than-expected ASP hike, which led 1Q topline to rise 170% yoy and GPM to expand by 41.7% pts yoy to 60.6%.
Glove shortage remains acute
We believe global glove shortage remains acute given the worsening pandemic crisis.
UGHC said its distribution companies&rsquo inventory levels remain low, and have to be managed on a very tight schedule based on just-in-time delivery.
We forecast UGHC to record blended ASP growth of +131% yoy in FY21F, boosting its topline to S$364.4m (+153% yoy).
UG price has been hit hard from 90c++ to 55c. Nay sayers have been trying very hard to make it to 50c then 45c.
Now they can capitalise on news release from Moderna this week, as same as Pfizer a few weks ago. They will try to pull it down further.
But they forget that covid-19 cases in USA have reached 17.5m this week, entering into an uncontrollable level!! How about 2021?
They desperately need besides various vaccines, also need masks, gloves, masks, PPE, healthcare and medical practitioners helps.
May all these concerted efforts helping them save more lives.
Now they can capitalise on news release from Moderna this week, as same as Pfizer a few weks ago. They will try to pull it down further.
But they forget that covid-19 cases in USA have reached 17.5m this week, entering into an uncontrollable level!! How about 2021?
They desperately need besides various vaccines, also need masks, gloves, masks, PPE, healthcare and medical practitioners helps.
May all these concerted efforts helping them save more lives.
UGH manufacture and distribute a wide range of Latex Examination Gloves and Nitrile Examination Gloves used in a wide range of industries such as healthcare (including medical examination procedures, diagnostic procedures and laboratories), food and beverage (particularly food handling) and the automotive industry. Don't think any vaccines can nullify its products diversified use. Hold for $1.20..